Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Cells|June 12, 2020
The Aquaporin3 Promoter Polymorphism -1431 A/G is Associated with Acute Graft Rejection and Cytomegalovirus Infection in Kidney Recipients Due to Altered Immune Cell MigrationKatharina Rump, Tim Rahmel, Anna-Maria Rustige, et al.
Neurology and Therapy|February 12, 2024
Dyskinesia and Pain in Advanced Parkinson's Disease: Post Hoc Analysis from the Phase 3b, Open-Label, Randomized DYSCOVER StudyEric Freire-Alvarez, Paola Vanni, Egon Kurča, et al.
Journal of Translational Medicine|November 23, 2016
AQP5-1364A/C polymorphism and the AQP5 expression influence sepsis survival and immune cell migration: a prospective laboratory and patient studyKatharina Rump, Matthias Unterberg, Lars Bergmann, et al.
International Journal of Molecular Sciences|July 27, 2022
The Pro-Inflammatory Deletion Allele of the NF-κB1 Polymorphism Is Characterized by a Depletion of Subunit p50 in SepsisBritta Marko, Paulina Heurich, Patrick Thon, et al.
Journal of Multidisciplinary Healthcare|January 25, 2017
The role and structure of the multidisciplinary team in the management of advanced Parkinson's disease with a focus on the use of levodopa-carbidopa intestinal gelStephen W Pedersen, Martin Suedmeyer, Louis W C Liu, et al.
Acta Neurologica Scandinavica|May 24, 2022
Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE-PD observational studyAlfonso Fasano, Victor S C Fung, Klaus Seppi, et al.
Scientific Reports|December 8, 2019
DNA methylation of a NF-κB binding site in the aquaporin 5 promoter impacts on mortality in sepsisKatharina Rump, Matthias Unterberg, Agnes Dahlke, et al.
Parkinsonism & Related Disorders|August 25, 2022
Motor and nonmotor symptoms in patients treated with 24-hour daily levodopa-carbidopa intestinal gel infusion: Analysis of the COmedication Study assessing Mono- and cOmbination therapy with levodopa-carbidopa inteStinal gel (COSMOS)Norbert Kovács, József Szász, Lydia Vela-Desojo, et al.
Movement Disorders Clinical Practice|May 19, 2022
Advanced-Stage Parkinson's Disease: From Identification to Characterization Using a Nationwide DatabaseYael Barer, Tanya Gurevich, Gabriel Chodick, et al.
Advances in Therapy|May 21, 2021
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic ReviewAngelo Antonini, Per Odin, Rajesh Pahwa, et al.
Pageof 9